The blueprint for Novel Science
A validated Approach to Transformational Impact
Grounded in science, we explore and validate novel targets with rigor and resolve, paving the way toward breakthrough therapies for immunological diseases and cancer.
We are taking a novel approach to targeting SIRP
Our portfolio of Signal Regulatory Protein (SIRP)–directed antibodies works via a unique mechanism of action and has the potential to address the underlying pathology across a broad range of diseases.
